DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Millot F, Guilhot J, Nelken B. et al.
Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation.
Leukemia 2006;
20 (02) 187-192
We do not assume any responsibility for the contents of the web pages of other providers.